Coating processes – Medical or dental purpose product; parts; subcombinations;... – Particulate or unit-dosage-article base
Reexamination Certificate
2006-08-15
2006-08-15
Meeks, Timothy (Department: 1762)
Coating processes
Medical or dental purpose product; parts; subcombinations;...
Particulate or unit-dosage-article base
C427S002140, C427S002240, C427S002310, C427S162000, C427S261000, C623S006420, C623S901000
Reexamination Certificate
active
07090888
ABSTRACT:
A method of making an ophthalmological implant by applying a layer of pharmaceutical agent and an overlying layer of a bioerodible material, a biodegradable material, a bloavailable material or a mixture thereof, the overlying layer having variable thickness and being dimensioned for prolonged release of the pharmaceutical agent from the implant as the overlying layer degrades.
REFERENCES:
patent: 4853224 (1989-08-01), Wong
patent: 5273751 (1993-12-01), Dubroff
patent: 5375611 (1994-12-01), Lindqvist et al.
patent: 5401880 (1995-03-01), Clark et al.
patent: 5554187 (1996-09-01), Rizzo, III
patent: 5569463 (1996-10-01), Helmus et al.
patent: 5616122 (1997-04-01), Lam et al.
patent: 5624704 (1997-04-01), Darouiche et al.
patent: 5743274 (1998-04-01), Peyman
patent: 5820917 (1998-10-01), Tuch
patent: 5843184 (1998-12-01), Cionni
patent: 5843186 (1998-12-01), Christ
patent: 5853760 (1998-12-01), Cremer
patent: 5876438 (1999-03-01), Kelleher et al.
patent: 5902283 (1999-05-01), Darouiche et al.
patent: 5980928 (1999-11-01), Terry
patent: 6162487 (2000-12-01), Darouiche
patent: 6206916 (2001-03-01), Furst
patent: 6322592 (2001-11-01), Lucas et al.
patent: 6352542 (2002-03-01), Snyder
patent: 2001/0004708 (2001-06-01), Nagai
patent: 2002/0099438 (2002-07-01), Furst
patent: 0544948 (1993-06-01), None
patent: 2001-018344 (2001-03-01), None
patent: WO 00/62760 (2000-10-01), None
patent: WO 01/32140 (2001-05-01), None
patent: WO 02/100318 (2002-12-01), None
patent: WO 03/061625 (2003-07-01), None
Pandey et al., Intracapsular ring sustained 5-fluorouracil delivery system for the prevention of posterior capsule opacification in rabbits: a histological study, J Cataract Refract Surg Jan. 28, 2002 (1): 139-48.
Shi W et al., Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant, Chung Hua Yen Ko Tsa Chih Aug. 38, 2002 (8): 502-5.
Mantripragada, S., A lipid based depot (DepoFoam technology) for sustained release drug delivery, Prog Lipid Res Sep. 2002 41 (5) 392-406.
Das et al., Effect of vancomycin on Staphylococcus epidermidis adherence to poly(methyl methacrylate) intraocular lenses, J Cataract Refract Surg Apr. 28, 2002 (4): 703-8.
Cheng et al., Treatment or prevention of herpes simplex virus retinitis withintravitreally injectable crystalline 1-0-hexadecylpropanediol-3-phospho-ganciclovir, Invest Ophthalmol Vic Sci Feb. 2002; 43 (2): 515-21.
Herrero-Vanrell et al., Biodegradable microspheres for vitreoretinal drug delivery, Adv Drug Deliv Rev Oct. 31, 2001; 52 (1): 5-16.
Herrero-Vanrell et al., Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process, Pharm Res Oct 2002; 17 (10): 1323-8.
Jaffe et al., Fluocinolone acetonide sustained drug delivery device to treat severe uveitis, Ophthalmology Nov 2000; 107 (11):2024-33.
Jaffe et al., Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device, Invest Ophthalmol Vis Sci Oct 2002; 41 (11); 3569-75.
Kunou et al., Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis, J Control Release Aug. 10, 2000; 68(2): 263-71.
Einmahl et al., Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester), Int J Pharm 1999 Aug 20; 185(2): 189-98.
Tetz et al., Inhibition of posterior capsule opacification by an intraocular-lens-bound sustained drug delivery system: an experimental animal study and literature review, J Cataract Surg Oct 1996; 22 (8): 1070-9.
Rabowsky et al., The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery, Ophthalmology May 1996; 103 (5): 800-7.
Nishi et al., Effect of intraocular sustained release of indomethacin on postoperative inflammation and posterior capsule opacification, J Cataract Refract Surg 1996; 22 Supp. 1: 806-10.
Chetoni et al., Ocular mini-Tablets for controlled release of timolol: evaluation in rabbits, J Ocul Pharmacol Ther 1996 Fall; 12 (3): 245-52.
Kiremitci-Gumusderelioglu et al., A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies, J Biomater Sci Polym Ed 1996; 7 (1): 857-69.
Borhani et al., Suppression of experiemental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU, Int Ophthalmol 1995; 19 (1): 43-9.
Joshi A., Microparticulates for ophthalmic drug delivery, J Ocul Pharmacol 1994 Spring; 10(1): 29-45.
Rahimy et al., Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations, J Drug Target 1994; 2 (4): 289-98.
Chang DF et al., Two Clinical trials of an intraocular steriod delivery system for cataract surgery, Trans AM Ophthalmol Soc. 1999; 97: 261-74; discussion 274-9.
DuBosar, Ryan, Intraocular steriod delivery system completes FDA phase 2 trial; New drug delivery system could make postop cataract managment easier and more efficient, Ocular Surgery News, a SLACK Incorporated newspaper, Nov. 1, 1997.
Chang, David F., An Intraocular Steriod Delivery System for Cataract Surgery, British Journal of Ophthalmology, Mar. 9, 2001.
Dobrusin Eric M.
Snyder Michael E.
Dobrusin & Thennisch PC
Markham Wesley D.
Meeks Timothy
LandOfFree
Sustained release ophthalmological device and method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release ophthalmological device and method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release ophthalmological device and method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617141